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The average age at onset of malignancies arising from epithelial tissues is between 40 and 70 years old even in
familial cancers. Although it is believed that the accumulation of multiple genetic alterations is needed for cancer
onset, we hypothesize–based on the diversity of ages at onset for most types of epithelial cancer–that there is a
postponing mechanism inside the human body that significantly delays the process of carcinogenesis. The key
molecules controlling the cancer onset, here called “postponers”, are hypothesized to be functioning in the indivi-
duals carrying susceptibility genes. As a consequence, cancers occur in middle age or even old age, with several
decades of cancer-free lifetime for the patient. Genome-wide association studies and genomic expression profiling
are suggested to identify candidate postponers. Hypothetic gene expression patterns for identifying candidate
postponers are illustrated. Animal models will be helpful to test whether the absence or presence of the postponer
molecules can alter the onset age of spontaneous tumors. If this hypothesis is true, by amplification of the post-
poning mechanism we might be able to significantly delay the onset of tumors, so that individuals carrying cancer
susceptibility traits could gain an additional significant period of cancer-free life. Moreover, destructive prophylactic
surgeries, e.g., for women who have BRCA1/2 gene mutations, might be avoided.
Introduction
Hereditary susceptibility has been increasingly recog-
nized to be an important etiological factor in many can-
cers. Familial aggregation is one of the phenotypes
reflecting the contribution of genetic factors in carcino-
genesis [1-4]. Genetic influences on cancer onset can
also present as geographic and racial aggregation in
some cancers. For example, nasopharyngeal carcinoma
(NPC) has the highest incidence rate in southern China
and Southeast Asia in populations with similar racial/
ethnic backgrounds [5,6].
In a study comparing the age of cancer onset, Brandt
and colleagues found that cancers in individuals with a
family history occur 2.6-16.3 years earlier than in spora-
dic patients [7]. The early onset in familial cases is
observed in a variety of malignancies, including leuke-
mia, non-Hodgkin lymphoma, and cancers arising in the
cervix, breast, nasopharynx, ovary, nervous system, col-
orectum, endometrium, bladder, lung, prostate, skin,
stomach, and pancreas [7,8]. These findings strengthen
the notion that genetic susceptibility plays an important
role in the carcinogenesis of a variety of cancers.
Thanks to advances in molecular technology, especially
genome-wide association studies (GWAS), one could
expect that in the near future susceptibility gene(s) could
be identified in more malignancies [9]. However, another
important question is then raised: if the genetic trait is
the main culprit, why does it show up so late for the
most common cancers arising in epithelial tissue, with
the average age of onset being 40-70 years old even in
the familial cancers, although the affected individual car-
ries the gene(s) from day 1 of his/her life?
The commonly accepted explanation for the delayed
onset of cancer is that accumulation of the genetic altera-
tions is needed for carcinogenesis. The multiple mutation
theory has been widely acknowledged for tumor initiation
[10]. Genetic variety inside a solid tumor correlating with
different invasiveness of the cells [11] further supports
the theory that multiple genetic alterations might be
needed for cancer formation and progression. If the accu-
mulation of multiple genetic alterations is needed, the
remarkable variety of age of onset within each type of
epithelial cancer suggests that the speed of this genetic
accumulation is different, probably controlled by a
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efficiencies. On another hand, the multiple mutation the-
ory is also challenged by the fact that a particular type of
cancer only develops in a small proportion of a popula-
tion heavily exposed to known chemical carcinogens
[12], suggesting that a postponing mechanism could be
functioning to prevent tumorigenesis in the lifetime of
the exposed population.
Another hypothetical explanation for the delayed
onset of cancer is that the immune system in the patient
prevents the disease onset in his/her childhood and ado-
lescence. However, most cancer patients, especially
those with early-stage disease, do not show impaired
immune function, weakening the rationale of the expla-
nation. Other unknown mechanism(s) in human body
may be acting to delay the cancer onset.
Figure 1 Hypothetic gene expression patterns in cancer patients and healthy controls in a population with the similar genetic
background. If both groups of cancer patients and healthy controls have a gene expressed in Pattern A, we can assume that this gene might
correlate to normal aging but not cancer onset. However, if a gene expression only correlates with the age of disease onset in cancer patients
(Pattern A) but does not correlate with normal aging in healthy controls (Pattern B), we can assume that this gene might correlate to the
postponing of cancer onset.
Qian Cancer Cell International 2010, 10:38
http://www.cancerci.com/content/10/1/38
Page 2 of 4Presentation of hypothesis
Herein, I hypothesize that there is a postponing mechan-
ism that significantly delays the process of epithelial car-
cinogenesis. The key molecules controlling cancer onset,
“postponers”, are hypothesized to be functioning in indi-
viduals carrying susceptibility genes. As a consequence,
cancers occur in middle age or even old age, with several
decades of cancer-free lifetime for the patients.
Testing the hypothesis
To test this hypothesis, comprehensive studies are needed.
The first task is to identify candidate postponer molecules.
Population-based GWAS might be helpful in identifying
candidates by comparison of the genetic differences
between cancer patients and healthy controls, and among
the cancer patients with different ages of onset.
Another approach to identifying postponer candidates
might be quantitative comparison of genomic expression
profiling among the tumors manifesting in patients of
different ages. For this strategy, the experiments should
be wisely designed to exclude the confounding factors
generated from normal aging. Figure 1 demonstrates
hypothetic patterns of gene expression that can provide
us some clues for identifying postponer candidate.
In vitro functional studies to confirm the biological
impacts of the identified postponer candidates would be
critical. Numerous approaches to evaluate the roles of
the candidate molecules on carcinogenesis, apoptosis,
senescence, and autophagy should be considered.
Appropriate animal models will be useful for testing
whether the presence or absence of the postponer candi-
dates can alter the onset age of spontaneous tumors. In
an animal model with homozygous Pten deletion in the
renal epithelia using the Cre-lox system, typical renal pel-
vic transitional cell carcinoma (urothelial carcinoma) can
be induced in old-age animals [13]. Although the animals
harbor the genetic alteration from their inception, the
tumor incidence is 18.2% in mice younger than 6 months
and increases to 57.1% in mice older than 1 year. The
late tumor occurrence of this animal model is consistent
with human renal pelvic transitional cell carcinoma, in
which the average age of tumor onset is 70 years old [14].
Therefore, this is one of the appropriate models to test
whether knock-out of postponer candidate(s) can expe-
dite cancer onset.
Implications of hypothesis
The identification of postponer molecules is important,
especially for personalized medicine aiming to provide
high quality of life to cancer patients. For example, aggres-
sive and destructive prophylactic surgical approaches,
including bilateral mastectomy and oophorectomy, have
been recommended for women with the BRCA1/2 gene
mutation [15,16]. If the effect of a postponing mechanism
for breast cancer can be amplified in these high-risk indivi-
duals to gain a significant period of cancer-free time (or
even their entire lifespan), these surgeries might then be
avoided.
Proving this hypothesis will also be helpful for improv-
ing cancer patients’ quality of life. In NPC, for example, as
hereditary factor(s) are identified in the future, the carriers
of genetic susceptibility might bear huge psychological
burdens due to lack of effective preventive approaches
within current medical practice. Strengthening or amplify-
ing the postponing mechanism might be the hope of these
individuals.
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